Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer

OBJECTIVES: Immune-checkpoint inhibitors (ICIs) combined with chemotherapy are more widely used than monotherapy and have shown better survival in patients with advanced non-small cell lung cancer (NSCLC) without oncogenic driver alterations. The monocyte-to-lymphocyte ratio (MLR) might predict the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Liang, Xiong, Anning, Wang, Shuyuan, Xu, Jianlin, Shen, Yinchen, Zhong, Runbo, Lu, Jun, Chu, Tianqing, Zhang, Wei, Li, Ying, Zheng, Xiaoxuan, Han, Baohui, Zhong, Hua, Nie, Wei, Zhang, Xueyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909005/
https://www.ncbi.nlm.nih.gov/pubmed/36776882
http://dx.doi.org/10.3389/fimmu.2023.1094378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909005/
https://www.ncbi.nlm.nih.gov/pubmed/36776882
http://dx.doi.org/10.3389/fimmu.2023.1094378

Ejemplares similares